Hypertrophic cardiomyopathy in late-onset variant of Fabry disease with high residual activity of alpha-galactosidase A.

doi:10.1111/j.1399-0004.1991.tb03018.x

Skip navigation

Results
This Paper

To show you the PDF, we need your affiliation

(Don't worry, you'll only have to do this once)

Affiliation:

Cancel

Hypertrophic cardiomyopathy in late-onset variant of Fabry disease with high residual activity of alpha-galactosidase A.

Y Y Nagao, H H Nakashima, Y Y Fukuhara, M M Shimmoto, A A Oshima, Y Y Ikari, Y Y Mori, H H Sakuraba and Y Y Suzuki Clin Genet 39(3):233-7 (1991) PMID 1645238

A new variant form of Fabry disease with hypertrophic cardiomyopathy of late onset is reported. Two unrelated male hemizygotes of this disease first presented with signs and symptoms of cardiomyopathy after 50 years of age. Cultured lymphoblastoid cells showed significantly higher residual alpha-galactosidase A activities than in the patients with classical phenotypic expressions.

DOI: 10.1111/j.1399-0004.1991.tb03018.x
Version: za2963e q8za2 q8zbb q8zc8 q8zdd q8ze9 q8zfa q8zg8

Advanced search Close

Limits Clear all Close

To show you the PDF, we need your affiliation

Hypertrophic cardiomyopathy in late-onset variant of Fabry disease with high residual activity of alpha-galactosidase A.

paper

citation

Log in to Pubget.